使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
Good day, and thank you for standing by. Welcome to the AMN Healthcare third-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
大家好,感謝您耐心等候。歡迎參加 AMN Healthcare 2024 年第三季財報電話會議。(接線員指示) 請注意,今天的會議將被錄音。
I would now like to hand the conference over to your first speaker today, Randle Reece, Senior Director, Investor Relations and Strategy. Please go ahead.
現在我想把會議交給今天的第一位講者,投資人關係與策略資深總監 Randle Reece。請開始。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
Good afternoon, everyone. Welcome to AMN Healthcare's third-quarter 2024 earnings call. A replay of this webcast will be available at ir.amnhealthcare.com at the conclusion of this call. Remarks we make during this call about future expectations, projections, trends, plans, events or circumstances constitute forward-looking statements. These statements reflect the company's current beliefs based upon information currently available to it.
各位下午好。歡迎參加 AMN Healthcare 2024 年第三季財報電話會議。本次網路直播的重播將於本通話結束後在 ir.amnhealthcare.com 提供。我們在本次通話中就未來預期、預測、趨勢、計畫、事件或情況所作的評論,構成前瞻性陳述。這些陳述反映公司基於目前可得資訊所持有的當前信念。
Our actual results may differ materially from those indicated by these forward-looking statements because of various factors and cautionary statements. including those identified in our most recently filed forms 10-K and 10-Q, our earnings release and subsequent filings with the SEC. The company does not intend to update guidance or any forward-looking statements provided today prior to its next earnings release. This call contains certain non-GAAP financial information. Information regarding and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in our earnings release and on our financial reports page at ir.amnhealthcare.com.
由於各種因素與警示性陳述,我們的實際結果可能與這些前瞻性陳述所示有重大差異,其中包括我們最近提交的 10-K 與 10-Q 表格、財報新聞稿以及其後向 SEC 提交的文件中所識別者。公司無意在下一次財報發布前更新今日提供的指引或任何前瞻性陳述。本通話包含若干非 GAAP 財務資訊。關於這些非 GAAP 指標及其與最直接可比 GAAP 指標之調節資訊,已載於我們的財報新聞稿,並可於 ir.amnhealthcare.com 的財務報告頁面查閱。
On the call with me today are Cary Grace, President and Chief Executive Officer; and Jeff Knudson, Chief Financial Officer. I will now turn the call over to Cary.
今天與我一同參與通話的有:總裁兼執行長 Cary Grace,以及財務長 Jeff Knudson。現在我把通話交給 Cary。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Thank you, Randy, and welcome to today's call. AMN Healthcare continues to build an attractive long-term story, while we simultaneously deal with a challenging post-market for our industry. Financial results for the third quarter of 2024 were above expectations. Revenue of $688 million was above the upper end of our guidance range and adjusted EBITDA of $74 million was above the consensus of sell-side analyst estimates. Excluding some beneficial discrete items, our revenue was in line with guidance.
謝謝你,Randy,也歡迎各位參加今天的通話。AMN Healthcare 一方面持續打造具吸引力的長期成長故事,同時也在應對本產業在市場後期所面臨的挑戰。2024 年第三季的財務結果優於預期。營收 6.88 億美元高於我們指引區間的上緣,調整後 EBITDA 7,400 萬美元亦高於賣方分析師一致預估。若排除部分有利的一次性項目,我們的營收與指引一致。
We continue to see signs of a stabilizing market with increasing demand for Travel Nurse staffing and healthy demand in most other staffing markets. We have also seen relatively stable bill rates for clinicians placed across our Nurse, Allied and Locums businesses and new order bill rates among our top clients are evenly divided between raising and lowering rates that some clients are raising rates is a significant change from the past six quarters. Nurse and Allied travelers on assignment have been stable since July. Demand for Travel Nurse staffing in recent weeks was 60% above the low point in April, so still about 35% below the 2019 order level. Any areas of improvement in market dynamics have had little effect on near-term performance, but we expect them to be increasingly visible as we go through 2025.
我們持續看到市場趨於穩定的跡象,旅遊護理(Travel Nurse)派遣需求增加,且多數其他派遣市場的需求也維持健康。我們也看到在護理、醫事專業(Allied)與代班醫師(Locums)業務中所派遣臨床人員的計費費率(bill rates)相對穩定;而在我們的主要客戶中,新訂單的計費費率在上調與下調之間大致各半——部分客戶正在上調費率,這相較於過去六個季度是顯著的變化。自 7 月以來,護理與醫事專業旅遊派遣人員在案人數維持穩定。近幾週旅遊護理派遣需求較 4 月低點高出 60%,但仍較 2019 年訂單水準低約 35%。市場動態的任何改善對短期表現影響不大,但我們預期在 2025 年期間將愈來愈明顯。
While competition to fill these orders has compressed industry gross margins this year, an increasing number of orders are priced below levels anyone will sell. Unfilled orders for Nurse and Allied and vendor-neutral programs increased from about 9% last quarter to 14% currently. Suppliers are increasingly not filling orders priced at levels that don't make economic sense. And clinicians expect to pay in line with broader wage and housing inflation. Our estimates indicate that travel nurse bill rates in the fourth quarter of 2024 have reached the low end of the 15% to 20% premium they maintained over the cost of permanent nurses prior to 2020, which could help explain the increase in unfilled orders in the industry.
雖然今年為了爭取填補這些訂單的競爭壓縮了產業毛利率,但愈來愈多訂單的定價已低於任何人願意承接的水準。護理與醫事專業以及供應商中立(vendor-neutral)專案的未填補訂單比例,從上季約 9% 上升至目前的 14%。供應商愈來愈不願填補那些定價在經濟上不合理的訂單。而臨床人員則期望薪酬能與更廣泛的薪資與住房通膨一致。我們的估計顯示,2024 年第四季旅遊護理的計費費率已降至 2020 年前相對於正式護理人員成本所維持之 15% 至 20% 溢價區間的低端,這可能有助於解釋產業未填補訂單增加的原因。
As conditions for health care labor continue to normalize, we expect margin pressure to subside as it did in past cycles. In some cases, the cost of alternatives to contingent staffing, are already more expensive. Reaching this point is likely an important milestone for our industry's return to an improved operating environment. Across our businesses, AMN is responding aggressively to the current state of our industry. We are committed to being the most capable partner for helping clients develop and reach their workforce goals.
隨著醫療人力市場狀況持續正常化,我們預期利潤率壓力將如同過往循環般逐步緩解。在某些情況下,替代臨時派遣人力的方案成本已更為昂貴。達到這一點很可能是本產業回到更佳營運環境的重要里程碑。在我們各項業務中,AMN 正積極回應目前的產業現況。我們致力成為最有能力的合作夥伴,協助客戶制定並達成其人力目標。
Our progress on internal fill rates across Nurse and Allied has been positive, though affected by the same market dynamics that have resulted in an increase in unfilled orders. While we are ensuring that our pricing is competitive, we are doing so while delivering outstanding value and quality to our clients and health care professionals. We continue to build powerful solutions around our outstanding technology. Since I joined AMN eight quarters ago, the team has moved us from a lagging technology position to an empowered position where our clients and prospects have access to leading tools and technology to help them manage their health care workforce. In the past few months, we moved to net positive on the MSP win-loss board for 2024, elevated by our improved competitive stance.
我們在護理與醫事專業的內部填補率(internal fill rates)方面取得正向進展,但也受到相同市場動態影響,導致未填補訂單增加。在確保定價具競爭力的同時,我們也持續為客戶與醫療專業人員提供卓越的價值與品質。我們持續圍繞我們出色的技術打造強大的解決方案。自我在八個季度前加入 AMN 以來,團隊已將我們從技術落後的位置推進到更具賦能的狀態,使客戶與潛在客戶能使用領先的工具與技術來管理其醫療人力。在過去幾個月,我們在 2024 年 MSP(管理服務供應商)競標勝負表上轉為淨正向,這得益於我們競爭態勢的改善。
Our recent client summit in Dallas resulted in a great reception for our new integrated technology suite we call Workwise. Workwise integrates workforce planning and reporting, predictive scheduling, vendor management solutions and candidate engagement. Our client demos last month resulted in consistently positive feedback, and we are energized about our market positioning. Throughout this year, we have seen increasing demand for total talent solutions. And our average number of solutions used by our top client has risen to approximately 10%.
我們近期在達拉斯舉辦的客戶高峰會,對我們稱為 Workwise 的全新整合式技術套件獲得非常好的反響。Workwise 整合了人力規劃與報表、預測性排班、供應商管理解決方案以及候選人互動。我們上個月的客戶展示持續獲得正面回饋,我們對自身的市場定位感到振奮。今年以來,我們看到對全方位人才(total talent)解決方案的需求增加。而我們前十大客戶平均使用的解決方案數量已上升至約 10%。
Because of our broad solution set, we are uniquely positioned to help clients build a sustainable workforce strategy. Now let's turn back and review our third quarter results by business segments. Nurse and Allied Solutions reported $399 million in revenue in the third quarter. better than consensus due primarily to several beneficial factors that increased revenue by approximately 2%. Core performance was as expected with about 1% upside in volume offset by bill rate and hours slightly below forecast.
由於我們擁有廣泛的解決方案組合,我們具備獨特優勢,能協助客戶建立可持續的人力策略。現在讓我們回頭按業務部門回顧第三季的業績。護理與醫事專業解決方案在第三季的營收為 3.99 億美元,優於市場一致預期,主要是因為數項有利因素使營收增加約 2%。核心表現符合預期,量(volume)約有 1% 的上行,但被計費費率與工時略低於預測所抵銷。
Segment operating margin of 8.8% was positively impacted by approximately 180 basis points from the favorable items. Physician and Leadership Solutions revenue for the quarter was $181 million, in line with consensus. Locum Tenens revenue of $142 million was up 26% year over year including the MSCR acquisition and down 3% organically. Volume for our organic locums business was modestly better than we had projected. Interim leadership and search continue to have lower demand.
該部門營運利潤率 8.8%,受上述有利項目正向影響約 180 個基點。醫師與領導力解決方案本季營收為 1.81 億美元,符合市場一致預期。代班醫師(Locum Tenens)營收 1.42 億美元,年增 26%,其中包含 MSCR 併購貢獻;若以有機口徑則年減 3%。我們有機代班業務的量略優於我們的預估。臨時領導(interim leadership)與搜尋(search)業務需求仍然偏弱。
Segment operating margin of 10% was lower than we had expected due to gross margin pressure primarily from mix. Technology and Workforce Solutions recorded third quarter revenue of $108 million, in line with consensus. Language Services, which had revenue of million, up 13% year over year, while several client disruptions caused by the crowd spike event and hurricanes in the third quarter that our teams help them manage through. We continue to see strong client interest in our language services solution. VMS revenue was $25 million in the third quarter, in line with our expectations.
該部門營運利潤率 10%,低於我們預期,主要因組合(mix)因素導致毛利率承壓。科技與人力解決方案第三季營收為 1.08 億美元,符合市場一致預期。語言服務(Language Services)營收為 百萬美元,年增 13%;同時,第三季因 CrowdStrike 事件與颶風造成的若干客戶營運中斷,我們的團隊協助客戶加以因應與管理。我們持續看到客戶對我們語言服務解決方案的強勁興趣。VMS 第三季營收為 2,500 萬美元,符合我們的預期。
Now I'll turn the call over to Jeff for more details about our results.
現在我把電話交給 Jeff,請他更詳細說明我們的業績。
Jeffrey Knudson - Chief Financial Officer, Treasurer
Jeffrey Knudson - Chief Financial Officer, Treasurer
Thank you, Cary, and good afternoon, everyone. Third quarter consolidated revenue was $688 million, above the high end of guidance. Revenue was down 19% from the third quarter of 2023 and down 7% sequentially, primarily due to lower volume in Nurse and Allied, interim and search businesses. Consolidated gross margin for the third quarter was 31%. Year over year, gross margin decreased 290 basis points, driven by lower margin across all three segments partly offset by a favorable revenue mix shift.
謝謝你,Cary,各位下午好。第三季合併營收為 6.88 億美元,高於財測區間上緣。營收較 2023 年第三季年減 19%,並較前一季季減 7%,主要因 Nurse and Allied、臨時(interim)與搜尋(search)業務量下滑。第三季合併毛利率為 31%。年比而言,毛利率下降 290 個基點,主因三個事業部門毛利率皆較低,部分被有利的營收組合轉移所抵銷。
Sequentially, gross margin was flat. Consolidated SG&A expenses were $150 million or 21.8% of revenue compared with $163 million or 19.1% of revenue in the prior year period and $149 million or 20.1% of revenue in the previous quarter. The decrease in SG&A expenses year over year was primarily due to lower employee and professional service expenses. Sequentially, SG&A expenses were flat. Adjusted SG&A, which excludes acquisition, integration and other costs, legal settlement accrual changes and stock-based compensation expense was $141 million in the third quarter or 20.5% of revenue compared with $157 million or 18.4% of revenue in the prior year period and $137 million or 18.5% of revenue in the previous quarter.
就季比而言,毛利率持平。合併 SG&A 費用為 1.50 億美元,占營收 21.8%,相較於去年同期為 1.63 億美元(占營收 19.1%),以及前一季為 1.49 億美元(占營收 20.1%)。SG&A 費用年比下降主要由於員工與專業服務費用較低。就季比而言,SG&A 費用持平。第三季調整後 SG&A(排除併購、整合及其他成本、法律和解準備金變動以及股份基礎給付費用)為 1.41 億美元,占營收 20.5%,相較於去年同期為 1.57 億美元(占營收 18.4%),以及前一季為 1.37 億美元(占營收 18.5%)。
Third quarter Nurse and Allied revenue was $399 million, down 30% from the prior year period and 10% from the previous quarter. primarily driven by lower volume and rates in Travel Nurse and lower volume in Allied. Average bill rate was down 8% year over year and 2% sequentially. The year over year volume decreased 24% and average hours worked were flat. Sequentially, volume was down 11%, while average hours work were flat.
第三季 Nurse and Allied 營收為 3.99 億美元,較去年同期下降 30%,較前一季下降 10%,主要由於 Travel Nurse 的量與價格下降,以及 Allied 的量下降所致。平均計費費率(average bill rate)年減 8%,季減 2%。年比量下降 24%,平均工時持平。季比量下降 11%,而平均工時持平。
Travel Nurse revenue in the third quarter was $244 million, a decrease of $0.37 from the prior year period and 12% from the prior quarter. Allied revenue in the quarter was $141 million down 16% year over year and 7% sequentially. Nurse and Allied gross margin in the third quarter was 25%, a decrease of 250 basis points year over year primarily due to deleveraging of housing and travel expenses. Sequentially, gross margin increased 120 basis points, mainly due to beneficial discrete items. Segment operating margin of 8.8% decreased 570 basis points year over year, mainly due to lower gross margin and deleveraging of SG&A expenses.
第三季 Travel Nurse 營收為 2.44 億美元,較去年同期下降 0.37,並較前一季下降 12%。本季 Allied 營收為 1.41 億美元,年減 16%,季減 7%。第三季 Nurse and Allied 毛利率為 25%,年比下降 250 個基點,主要因住房與差旅費用的槓桿效益下降(deleverage)。就季比而言,毛利率上升 120 個基點,主要由於有利的一次性(discrete)項目。部門營業利益率為 8.8%,年比下降 570 個基點,主要因毛利率較低以及 SG&A 費用槓桿效益下降。
Sequentially, segment operating margin decreased 160 basis points driven primarily by prior quarter favorable insurance actuarial adjustments and continued deleveraging on lower revenue. Moving to the Physician Leadership Solutions segment. Third quarter revenue of $181 million increased 13% year over year with the growth coming from the MSTR acquisition. Sequentially, revenue was down 3% and driven primarily by lower volume in the search business. Locum Tenens revenue in the quarter was $142 million, up 26% year over year, driven by the MSTR acquisition.
就季比而言,部門營業利益率下降 160 個基點,主要受前一季有利的保險精算調整以及在較低營收下持續出現槓桿效益下降所致。接著看 Physician Leadership Solutions 部門。第三季營收 1.81 億美元,年增 13%,成長來自 MSTR 併購。就季比而言,營收下降 3%,主要由搜尋(search)業務量較低所致。本季 Locum Tenens 營收為 1.42 億美元,年增 26%,由 MSTR 併購帶動。
Sequentially, revenue was flat. Interim leadership revenue of $29 million decreased 7% from the prior year period and 5% sequentially. Service revenue of $10 million was down 38% year over year and 23% sequentially. Gross margin for the Physician Leadership Solutions segment was 28.3%, down 510 basis points year over year and 220 basis points sequentially. The decrease in gross margin is primarily attributable to a lower bill pay spreads in Locum tenants and a revenue mix shift.
就季比而言,營收持平。臨時領導(interim leadership)營收為 2,900 萬美元,較去年同期下降 7%,較前一季下降 5%。服務營收為 1,000 萬美元,年減 38%,季減 23%。Physician Leadership Solutions 部門毛利率為 28.3%,年比下降 510 個基點,季比下降 220 個基點。毛利率下降主要歸因於 Locum Tenens 的計費與薪酬價差(bill-pay spreads)較低,以及營收組合轉移。
Segment operating margin was 10% and which decreased 350 basis points year over year, primarily due to lower gross margin, partially offset by SG&A leverage from higher revenue. Sequentially, operating margin decreased 160 basis points due to lower gross margin. Technology and Workforce Solutions revenue for the third quarter was $108 million, down 11% year over year as the revenue growth in Language Services was more than offset by the decrease in the BMS business. Sequentially, revenue was down 4%, primarily attributable to the VMS business. Language Services revenue for the quarter was $75 million, an increase of 13% year over year and flat sequentially.
部門營業利益率為 10%,年比下降 350 個基點,主要因毛利率較低,部分被較高營收帶來的 SG&A 槓桿效益所抵銷。就季比而言,營業利益率下降 160 個基點,原因為毛利率較低。第三季 Technology and Workforce Solutions 營收為 1.08 億美元,年減 11%,因 Language Services 的營收成長被 BMS 業務下滑所抵銷。就季比而言,營收下降 4%,主要歸因於 VMS 業務。本季 Language Services 營收為 7,500 萬美元,年增 13%,季比持平。
VMS revenue for the quarter was $25 million, a decrease of 34% year over year and 9% sequentially. Segment gross margin was 57.9% down from 65% in the prior year period, primarily due to a revenue mix shift away from the VMS and outsourced solutions businesses. Sequentially, gross margin declined 230 basis points mainly due to lower margin in Language Services and a revenue mix shift. Segment operating margin in the third quarter was 39%, a decrease of 310 basis points from the prior year period driven primarily by lower gross margin, partially offset by expense management. Sequentially, lower gross margin led to segment operating margin decreasing 310 basis points.
本季 VMS 營收為 2,500 萬美元,年減 34%,季減 9%。部門毛利率為 57.9%,低於去年同期的 65%,主要因營收組合轉向遠離 VMS 與外包解決方案業務。就季比而言,毛利率下降 230 個基點,主要因 Language Services 毛利率較低以及營收組合轉移。第三季部門營業利益率為 39%,較去年同期下降 310 個基點,主要由較低毛利率所致,部分被費用管理所抵銷。就季比而言,較低毛利率導致部門營業利益率下降 310 個基點。
Third quarter consolidated adjusted EBITDA was $74 million, a decrease of 45% year over year and 21% sequentially. Adjusted EBITDA margin for the quarter was 10.7% down from 15.7% in the prior year period, primarily due to lower gross margin and deleveraging on lower revenue. Sequentially, adjusted EBITDA margin was down 200 basis points driven by the favorable actuarial adjustments for professional liability insurance in the prior quarter and the deleverage on lower revenue. Third quarter net income was $7 million, down 87% year over year and 57% sequentially. Third quarter GAAP diluted earnings per share was $0.18.
第三季合併調整後 EBITDA 為 7,400 萬美元,年減 45%,季減 21%。本季調整後 EBITDA 利潤率為 10.7%,低於去年同期的 15.7%,主要因毛利率較低以及在較低營收下出現槓桿效益下降。就季比而言,調整後 EBITDA 利潤率下降 200 個基點,原因為前一季專業責任保險的有利精算調整,以及在較低營收下的槓桿效益下降。第三季淨利為 700 萬美元,年減 87%,季減 57%。第三季 GAAP 稀釋每股盈餘為 0.18 美元。
Adjusted earnings per share for the quarter was $0.61 compared with $1.97 in the prior year period and $0.98 in the prior quarter. Days sales outstanding for the quarter was three days lower than the prior quarter and one day lower than a year ago. Since the start of 2024, we have reduced our DSO by 10 days. Operating cash flow for the third quarter was $67 million, and capital expenditures were $19 million. As of September 30, we had cash and equivalents of $31 million, long-term debt of $1.1 billion including a $285 million draw on our revolving line of credit and a net leverage ratio of 2.8 times 1.
本季調整後每股盈餘為 0.61 美元,相較於去年同期的 1.97 美元以及前一季的 0.98 美元。本季應收帳款週轉天數(DSO)較前一季減少 3 天,較一年前減少 1 天。自 2024 年初以來,我們已將 DSO 降低 10 天。第三季營運現金流為 6,700 萬美元,資本支出為 1,900 萬美元。截至 9 月 30 日,我們持有現金及約當現金 3,100 萬美元,長期負債 11 億美元,其中包括動用循環信用額度 2.85 億美元,淨槓桿比率為 2.8 倍 1。
During the quarter, we paid off $60 million of revolver debt bringing the year-to-date pay down to $175 million. We proactively increased the maximum leverage covenant on our revolving line of credit from 4 to 4.5 times through the end of 2025. We remain focused on paying down debt and returning to our target leverage ratio of 2 to 2.5 times. For the fourth quarter, we project consolidated revenue to be in the range of $685 million to $705 million, down 14% to 16% from the prior year period. Gross margin is projected to be between 29.3% and 29.8%.
在本季度內,我們償還了 6,000 萬美元的循環信貸(revolver)債務,使年初至今的償還總額達到 1.75 億美元。我們主動將循環信貸額度的最高槓桿比率契約由 4 倍提高至 4.5 倍,並延長至 2025 年底。我們仍專注於償還債務,並回到 2 至 2.5 倍的目標槓桿比率。對於第四季,我們預估合併營收將介於 6.85 億至 7.05 億美元,較去年同期下降 14% 至 16%。毛利率預估介於 29.3% 至 29.8%。
Reported SG&A expenses are projected to be 21.5% to 22% of revenue. Operating margin is expected to be 1.8% to 2.5% and adjusted EBITDA margin is expected to be 9.2% to 9.7%. Average diluted shares outstanding are projected to be approximately $38.4 million. Additional fourth quarter guidance details can be found in today's earnings release.
申報的 SG&A(銷售、一般及行政)費用預估為營收的 21.5% 至 22%。營業利益率預期為 1.8% 至 2.5%,調整後 EBITDA 利潤率預期為 9.2% 至 9.7%。平均稀釋流通股數預估約為 3,840 萬股。更多第四季指引細節可參見今日發布的財報新聞稿。
Now, I will hand the call back to Cary to further discuss fourth quarter guidance.
現在,我將把電話交回給 Cary,進一步討論第四季指引。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Thank you, Jeff. As Jeff finishes his final earnings call at AMN I want to thank him for everything he has done for the company in his three years as CFO. Jeff embodies AMN's strong core values and has been a steady hand through a wide range of market conditions. I personally appreciated his partnership as I joined AMN and I can say with certainty that he will be missed, and we wish him much success in his new endeavor. Our fourth quarter outlook includes headwinds and tailwinds that are characteristic of current market conditions.
謝謝你,Jeff。在 Jeff 完成他在 AMN 的最後一次財報電話會議之際,我想感謝他在擔任 CFO 的三年間為公司所做的一切。Jeff 體現了 AMN 強而有力的核心價值,並在各種市場環境下都能穩健掌舵。我個人非常感謝在我加入 AMN 時他所提供的合作與支持;我也可以很確定地說,我們會想念他,並祝福他在新的職涯發展中一切順利。我們對第四季的展望同時包含逆風與順風,這些都反映了當前市場狀況的特徵。
The low end of our revenue guidance range for the fourth quarter is 1% higher than the consensus estimate. This revenue outlook includes $45 million in revenue, we don't expect to recur in Q1 driven by labor disruption. For the fourth quarter, our outlook for Nurse and Allied Solutions revenue is 4% higher than the prior quarter. The other two segments have a revenue outlook about 5% below consensus estimates. For physician and leadership solutions, we're calling for revenue to be 4% lower sequentially in Q4, in line with normal seasonality.
我們第四季營收指引區間的低端比市場共識預估高出 1%。此營收展望包含 4,500 萬美元的營收,我們預期該部分由勞動中斷所帶動,且在第一季不會重複出現。第四季,我們對護理與醫事專業解決方案(Nurse and Allied Solutions)營收的展望較前一季高出 4%。另外兩個事業部的營收展望約比市場共識預估低 5%。在醫師與領導力解決方案(Physician and Leadership Solutions)方面,我們預期第四季營收將較前一季下降 4%,符合正常季節性。
In Technology and Workforce Solutions, we expect the revenue trend for language services to remain seasonally flat in Q4, while VMS should trend sequentially lower in volume in hours in line with the staffing market. At the midpoint of our adjusted EBITDA margin guidance of 9.2% to 9.7%. There is an approximately 125 basis point benefit due to the Nurse and Allied revenue that we do not expect to recur in Q1, including a benefit of 60 basis points to consolidated gross margin. While the market remains competitive after nearly two years of downward pressure, we see broader evidence of normalization in the staffing market, which could help us as we go through 2025. Our number of travelers on assignment declined through the first seven months of the year.
在科技與人力資源解決方案(Technology and Workforce Solutions)方面,我們預期語言服務的營收趨勢在第四季將維持季節性持平;而 VMS 的工時量將隨人力派遣市場走勢而呈現較前一季下滑。以我們調整後 EBITDA 利潤率指引 9.2% 至 9.7% 的中點來看,由於護理與醫事專業營收中有一部分我們預期第一季不會重複出現,因此約帶來 125 個基點的利多,其中包含對合併毛利率約 60 個基點的助益。儘管市場在近兩年的下行壓力後仍具競爭性,我們看到人力派遣市場更廣泛的正常化跡象,這可能在我們邁入 2025 年時對我們有所幫助。我們在派遣中的旅派人員(travelers)數量在今年前七個月持續下降。
In September, traveler count was slightly higher than July and this stabilization has continued in the fourth quarter. Some clients are starting to raise bill rates in certain hard-to-fill specialties as well as in areas where they need to increase capacity to meet strong patient demand. These are reasons for optimism, and we expect labor scarcity to reemerge as one of our industries driving forces next year.
9 月的旅派人員數量較 7 月略高,而這種穩定態勢在第四季仍持續。部分客戶已開始在某些難以補足的人才專科,以及需要提升產能以滿足強勁病患需求的地區,提高計費費率(bill rates)。這些都是令人樂觀的理由,我們預期明年勞動力稀缺將再度成為推動本產業的重要力量之一。
Now, operator, please open the call for questions.
現在,接線員,請開放提問。
Operator
Operator
(Operator Instructions) Trevor Romeo, William Blair.
(接線員指示)Trevor Romeo,William Blair。
Trevor Romeo - Analyst
Trevor Romeo - Analyst
First of all, Jeff, great working with you the couple of years, best of luck going forward. I wanted to, I guess, maybe first to circle back on the margin outlook. Maybe based on some of those comments at the end from Cary, I think we've heard a lot about gross margin pressure across the industry. It sounds like the guidance also includes some onetime benefit you called out, maybe excluding that, maybe it's in the 8% for EBITDA margin if that kind of makes sense. Just thinking ahead, if we don't see much improvement in gross margins, can you kind of talk about some of the puts and takes for SG&A going forward?
首先,Jeff,這幾年與你合作很愉快,祝你未來一切順利。我想先回到利潤率展望。根據 Cary 最後的一些評論,我想我們已經聽到很多關於整個產業毛利率承壓的情況。聽起來指引也包含你提到的一次性利多;若排除該因素,EBITDA 利潤率可能在 8% 左右(如果這樣理解合理的話)。往前看,如果毛利率沒有太大改善,你能否談談未來 SG&A 的一些增減因素(puts and takes)?
Maybe for one, just how you plan to balance recruiter capacity and such. Ultimately, I guess, trying to get at whether you think sort of that maybe 8%, 9% is the new normal? Or just any thoughts on that would be really helpful.
例如,你打算如何在招募人員(recruiter)產能等方面取得平衡。最終我想了解的是,你是否認為大約 8%、9% 可能會成為新的常態?或任何相關想法都會非常有幫助。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. Trevor, thanks for the question. So if we think -- and I'll start with what would drive gross margin improvement. And so if we look at what has impacted our gross margin at different points throughout the year. It's really been a combination of mix as well as pressure around bill pay spreads.
是的。Trevor,謝謝你的提問。如果我們思考——我先從推動毛利率改善的因素談起。如果我們回顧今年不同時間點影響我們毛利率的因素,主要是產品/業務組合(mix)以及計費與薪酬價差(bill-pay spreads)承壓的綜合結果。
And so if you would go back and look at what could positively impacted for us because we have a very broad, diverse set of solutions, seeing some recovery in some of those higher-margin solutions within each of our segments. So that would look like VMS in our TWS solution, search and interim and POS. And then we also have a large, high-margin international Nurse business that has been affected this year and into next year by Visa retrogression. We expect that headwind to taper off in the second quarter of 2025. So the first thing that would help us from a gross margin standpoint would be the favorable mix of our businesses going the other way as we start to see growth.
因此,如果你回頭看,哪些因素可能對我們有正面影響:由於我們擁有非常廣泛且多元的解決方案組合,我們在各事業部中一些較高毛利解決方案若出現復甦,將會帶來助益。例如在我們的 TWS 解決方案中,VMS、搜尋(search)、臨時派任(interim)以及 POS。此外,我們也有規模龐大且高毛利的國際護理業務,今年以及明年受到簽證排期倒退(Visa retrogression)的影響。我們預期該逆風將在 2025 年第二季趨於減弱。因此,從毛利率角度來看,第一個能幫助我們的因素,是當我們開始看到成長時,業務組合朝更有利的方向轉變。
We see very competitive conditions across all of our businesses. And so if you start to see some improvement in bill pay spreads. That would also help. And then the third lever when you go down from an EBITDA margin standpoint is we would expect, as you start to see some of that improvement and you've seen us do this throughout the past two years. is for us to look at ways where we can start getting some offsets to, I'd say, kind of natural labor cost headwinds, number one. And then as we get some of this higher-margin business growth, getting some leveraging of our SG&A.
我們在所有業務中都看到非常競爭的環境。因此,如果計費與薪酬價差(bill-pay spreads)開始改善,也會有所幫助。接著,從 EBITDA 利潤率角度往下看,第三個槓桿是:當你開始看到一些改善時——而且你也看到我們在過去兩年一直這麼做——我們會尋找方法來取得一些抵銷,我會說,首先是抵銷自然的勞動成本逆風。其次,當我們的高毛利業務開始成長時,也能讓我們在 SG&A 上取得一定的槓桿效益。
Trevor Romeo - Analyst
Trevor Romeo - Analyst
Okay. That's helpful. And then maybe hitting on that broader solutions point, on language services, I just wanted to ask on that, if that continues to, I guess, kind of become a larger part of the company from a revenue, but it seems like especially an EBITDA perspective. I was just wondering if you could share any updated metrics there maybe your growth outlook for, say, the medium term, including how much cross-selling runway you have left? And then also what kind of margins that business is running at nowadays?
好的。這很有幫助。另外回到更廣泛的解決方案這點,關於語言服務,我想問的是:如果它持續在營收上、尤其在 EBITDA 的角度,成為公司更大的一部分,我想知道你是否能分享一些更新的指標,例如中期的成長展望,包括你們還有多少交叉銷售(cross-selling)的空間?另外,該業務目前的利潤率大概是多少?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. So we love the language services business. We continue to see very healthy client demand in that space. It is a high-margin business for AMN within the TWS segment, it is a lower margin business. If you look at Q3, our quarterly revenue growth was affected by a delayed ramp of a single large new client that we've talked about through the course of this year, partially due to hurricanes.
是的。所以我們很喜歡語言服務業務。我們持續看到該領域非常健康的客戶需求。對 AMN 而言,這在 TWS 分部內屬於高毛利業務,但它本身是較低毛利的業務。如果你看第三季,我們的季度營收成長受到一位大型新客戶導入進度延後的影響;我們今年一路都有提到這件事,部分原因是颶風。
We expect the ramp-up of the clients to resume in Q1. So you should expect as we go into next year to see a ramp-up of growth in that business.
我們預期客戶的導入加速將在第一季恢復。因此,你應該預期我們進入明年後,該業務的成長會再度加速。
Trevor Romeo - Analyst
Trevor Romeo - Analyst
But generally, double digits is still kind of what you're thinking for the near term?
但整體來說,短期內你仍然是以雙位數成長作為預期嗎?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Double digits and 40%-plus gross margin.
雙位數成長,以及 40% 以上的毛利率。
Trevor Romeo - Analyst
Trevor Romeo - Analyst
Got it. Okay. And then just maybe one really quick other one would be, I think you mentioned, Cary, the Street item is benefiting Q2 revenue -- our Q3 revenue by 2% for Nurse and Allied. Could you just expand on what those were?
了解。好。另外再很快問一個,我想你提到,Cary,華爾街那個項目讓第二季營收——讓我們第三季的營收在護理與醫療輔助(Nurse and Allied)方面受益 2%。你能否再多說明一下那些是什麼?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. I'll turn it over to Randy, and you can give some details.
是的。我把問題交給 Randy,請他提供一些細節。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
They were primarily a sales allowance and SLA true-up in the Nurse and Allied segment in the third quarter. The consolidated gross margin, excluding the discrete items, would have been 30%. So it benefited by about 100 basis points.
主要是在第三季護理與醫療輔助分部的銷售折讓(sales allowance)以及 SLA(服務水準協議)調整(true-up)。若排除這些一次性項目,合併毛利率本來會是 30%。因此大約帶來 100 個基點的提升。
Operator
Operator
Mark Marcon, Robert W. Baird.
Mark Marcon,Robert W. Baird。
Mark Marcon - Analyst
Mark Marcon - Analyst
Jeff, best of luck in future endeavors. It's been a pleasure working with you over the last three years. I really appreciate all the help. Can we talk a little bit about where you really appreciate the guidance for the fourth quarter. If we just take a look at Travel Nursing, without that $45 million benefit for the -- for some of the labor disruption work, where would the fourth quarter guide be for just for travel nursing?
Jeff,祝你未來一切順利。過去三年能與你合作很愉快。我非常感謝你所有的協助。我們能否談談第四季指引?我很感謝你們提供的指引。如果我們只看旅遊護理(Travel Nursing),不包含那 4,500 萬美元的——部分勞動力中斷(labor disruption)工作帶來的效益,那麼第四季針對旅遊護理本身的指引會是多少?
Randle Reece - Investor Relations
Randle Reece - Investor Relations
Well, all of the revenue that is in that $45 million, which -- most of which is the labor disruption. There are a couple of other items. It's -- it would be -- you take all the $45 million out of Travel Nurse or out of Nurse and Allied.
嗯,那 4,500 萬美元中的所有營收——其中大部分是勞動力中斷。另外還有幾個其他項目。也就是——你把那 4,500 萬美元全部從旅遊護理,或從護理與醫療輔助中扣除。
Mark Marcon - Analyst
Mark Marcon - Analyst
Right. I got that, Randy. I just meant if we just look at just the pure travel nursing, what would the year-over-year decline be? Or said another way, what percentage of Nurse and Allied would you expect to be travel nursing?
對。我明白了,Randy。我只是想問,如果我們只看純粹的旅遊護理,年對年會下滑多少?或者換個說法,你們預期護理與醫療輔助中有多少比例會是旅遊護理?
Randle Reece - Investor Relations
Randle Reece - Investor Relations
Yes. Let's take that offline.
是的。我們私下再談。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Mark, if you -- if I go back to the guidance that we gave for Nurse and Allied last quarter, we had said, hey, we can see some scenarios where we would expect to be slightly down to flat to slightly up. If you take away the strike guidance that we gave you. And so relative to that -- to the guidance we gave before, our outlook for core NAS Q3 to Q4 is flat to down low single digits. So it is in line with what we had talked about last quarter.
Mark,如果我回到我們上季給的護理與醫療輔助指引,我們當時說,嘿,我們可以看到一些情境,預期可能會小幅下滑到持平,或小幅成長。如果把我們給你的罷工(strike)指引拿掉的話。因此相較於——相較於我們之前給的指引,我們對核心 NAS 從第三季到第四季的展望是持平到低個位數下滑。所以這與我們上季談到的內容一致。
Mark Marcon - Analyst
Mark Marcon - Analyst
Okay. Great. That's really helpful. I appreciate that. And can you talk a little bit more about just what you're seeing, both in terms of the orders that you feel a relevant in fillable and pricing and also supply and thinking about beyond the fourth quarter as we start thinking out towards the first quarter, because in a certain sense, it seems like things are basing out and we're starting to hit a bottom.
好的。很好。這真的很有幫助。謝謝。你能否再多談一些你們看到的情況,包括你們認為相關、可填補(fillable)的訂單與定價,以及供給端;並且在我們開始展望第四季之後、往第一季看時,你們怎麼思考?因為某種程度上,看起來情況正在築底,我們開始觸底。
But there's a couple of elements that make you wonder a little bit about that. And so I'm just trying to get a better sense for how you're thinking about that when you parse through all of the elements and specifically with regards to Travel Nursing.
但有幾個因素又讓人對此有點疑慮。所以我想更清楚了解,當你把所有因素拆解後,你們是如何思考的,尤其是針對旅遊護理。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. So if -- you take some of the comments that I made generally about some of the signs that we're seeing broadly around stabilization, whether that's in bill rate stability, the demand getting back to very well in actually the low end range of contingent premium spend to permanent costs. The things, Mark, that you would still want to see are -- we still see clients underneath that in different places. And so we have some clients to get orders billed, will increase bill rates. We have some that are still trying to decrease them.
是的。所以——如果你把我先前提到的一些更廣泛的穩定化跡象放在一起看,無論是計費費率(bill rate)的穩定、需求回到——其實是回到臨時人力溢價支出相對於正式人力成本的低端區間。Mark,你仍然希望看到的是——我們仍看到不同客戶處在不同位置。因此我們有些客戶為了讓訂單能夠被承接,會提高計費費率。也有一些客戶仍在嘗試降低費率。
and we see clients in different places on utilization as well. So while we've certainly seen progress, we want to see continued progress on that front. We have seen, as I mentioned in my opening comments, an uptick in unsold orders, which I think is significant given that it is an incredibly competitive environment. On balance, we probably have overcapacity in the Travel Nurse industry right now. You're starting to see some of that rationalize out.
而且我們也看到客戶在使用率(utilization)方面處於不同階段。所以雖然我們確實看到進展,但我們希望在這方面能持續改善。如我在開場所提到,我們看到未售出訂單(unsold orders)有所上升;我認為這很重要,因為目前競爭環境極為激烈。整體而言,旅遊護理產業目前可能存在產能過剩。你開始看到其中一部分正在被出清、合理化。
But you still see a very competitive environment and unsold orders increasing. So I think you'd want to see some of those orders getting cleared by getting better matching expectations between the clients and the clinicians.
但你仍然會看到非常競爭的環境,以及未售出訂單增加。所以我認為你會希望看到,透過讓客戶與臨床人員之間的期待更一致,來把其中一些訂單消化掉。
Mark Marcon - Analyst
Mark Marcon - Analyst
Great. And then what's your expectation on the VMS side? Because that would also be an indicator with regards to what we're seeing with regards to general order levels because you're obviously filling your orders first. And then on the MSP side, how -- what are the trends there, just broadly speaking?
很好。那你們對 VMS 端的預期是什麼?因為那也會是觀察整體訂單水位的指標,畢竟你們會先填自家的訂單。另外在 MSP 端,整體趨勢如何——大致上?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. And so what I would say on the VMS side is that does track the broader market. VMS was down in the third quarter, we expect it to be down in the fourth quarter. And I would say we're seeing plus or minus similar patterns across the industry. Again, you have clients in different places.
是的。我對 VMS 端的看法是,它確實會跟隨更廣泛的市場。VMS 在第三季下滑,我們預期第四季也會下滑。而且我會說,我們在整個產業看到的模式大致相同、上下差不多。同樣地,你會看到客戶處在不同位置。
So underneath any of the trends, we would have some MSP clients that may be increasing this quarter, and we have some that would be decreasing. If that's the industry trend, the other piece that we are seeing is we have been very focused on growing our portfolio we have moved in MSPs to a net win position year to date this year versus a net loss position last year.
所以在任何趨勢之下,我們會有一些 MSP 客戶本季可能增加,也會有一些可能減少。如果那是產業趨勢,另外一點是,我們一直非常專注於擴大我們的組合;今年迄今我們在 MSP 上已轉為淨贏(net win)態勢,相較於去年是淨流失(net loss)。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
Mark, we also mentioned in the prepared remarks that within our vendor-neutral and VMS business, there had been an increase during the quarter in unfilled orders, which is an indication of how many orders might be mispriced versus the market. In addition, in our VMS is we are hopeful and see a path to resuming sequential growth in revenue sometime next year.
Mark,我們也在事先準備的講稿中提到,在我們的中立供應商(vendor-neutral)與 VMS 業務中,本季未填補訂單(unfilled orders)有所增加,這顯示有多少訂單可能相對於市場而言定價不當。此外,就我們的 VMS 而言,我們抱持希望,並且看到一條路徑,能在明年某個時點恢復營收的連續(逐季)成長。
Mark Marcon - Analyst
Mark Marcon - Analyst
Great. And then one last one. When we take a look at the deleveraging that you're experiencing in terms of the SG&A and the margin profile there. Does that -- is that partially because you're maintaining some capacity with the thought that, hey, we're getting some stabilization? And do you feel like you've got excess capacity at this point in terms of recruiters, account managers, et cetera? And if so, how should we think about the incremental margins when things eventually turn.
很好。然後最後一個問題。當我們看你們在銷售、一般及行政費用(SG&A)以及那裡的利潤率輪廓所呈現的去槓桿情況時。那是否——部分原因是你們在維持一定的產能,因為你們認為,嘿,市場正在出現一些穩定跡象?而且就招募人員、客戶經理等等而言,你們覺得目前有過剩產能嗎?如果有,那麼當情況最終反轉時,我們應該如何看待增量利潤率?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
So you should think about our capacity on two fronts. One, we would expect to get some productivity off of our current producer base as market conditions improve. So we do think that there is capacity, particularly as we complete some of the automation projects that we've been focused on over the past couple of quarters. We also have embedded capacity within our internal -- our international nurse business.
所以你應該從兩個面向來看我們的產能。第一,隨著市場狀況改善,我們預期現有的業務開發人員(producer)團隊會提升一些生產力。因此我們確實認為存在產能,特別是在我們完成過去幾個季度一直專注的部分自動化專案之後。我們在內部——我們的國際護理業務中——也有內嵌的產能。
And so we have been very intentionally during this temporary period of visa retrogression to keep all of our candidates in line and ready to go. So as the retrogression dates improve, we can immediately get our candidates placed in the client that have requested them. So there's capacity from that front, Mark, that we would expect you to start seeing in 2025.
因此,在這段簽證倒退(visa retrogression)的暫時期間,我們一直非常有意識地讓所有候選人保持在隊列中並隨時待命。所以當倒退日期改善時,我們可以立即把候選人安置到提出需求的客戶那裡。所以從這個面向來看,Mark,我們預期你會在2025年開始看到這部分產能的釋放。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
Mark, when -- we if we were to add $100 million back of the international nurse revenue, we believe it would improve our consolidated adjusted EBITDA margin by 100 basis points. That's one of the best levers that we will have in terms of improving operating leverage, and we would expect to resume growth in 2026.
Mark,如果——如果我們把國際護理收入加回1億美元,我們相信這會讓我們的合併調整後EBITDA利潤率提升100個基點。就提升營運槓桿而言,這是我們手上最好的槓桿之一,而且我們預期在2026年恢復成長。
Operator
Operator
AJ Rice, UBS.
AJ Rice,瑞銀(UBS)。
AJ Rice - Analyst
AJ Rice - Analyst
A couple of ones, and then I want to just ask you about '25, make sure I get the run rate we're exiting the year at. But specifically, you're saying you picked out your net wins on MSP, but we're also talking about increased competition on the bill pay spread and other places. Is there anything about the MSP economics that's become more competitive, is the competitive landscape reflecting itself in competition for MSPs as well?
我有幾個問題,然後我想再問一下關於2025年,確認一下我們在年底退出時的運行率(run rate)。但具體來說,你們說你們挑出了MSP的淨新增勝出(net wins),但我們也在談帳單與薪資價差(bill-pay spread)以及其他地方競爭加劇。MSP的經濟性有沒有任何變得更具競爭性的地方?競爭格局是否也反映在MSP的競爭上?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. The competitive landscape is intense across the entire -- across all service models, A.J. And a number of features of MSPs particularly just how much lead time you had changed during COVID. And so I wouldn't say that there's anything unique about MSPs relative to the overall market, the entire market is competitive.
是的。競爭格局在整個——在所有服務模式上都很激烈,A.J.。而且MSP的一些特徵,特別是你需要多少前置時間(lead time),在COVID期間發生了變化。所以我不會說MSP相對於整體市場有什麼獨特之處;整個市場都很競爭。
AJ Rice - Analyst
AJ Rice - Analyst
Okay. And on the locums business, I think you mentioned the specialty mix dynamics was having some impact on margin. Can you comment on what types of its you're making, where the strength in placements is right now in locums and maybe elaborate a little more on that if I got it right, that's a margin pressure?
好的。關於臨時醫師(locums)業務,我想你提到專科組合(specialty mix)的動態對利潤率有一些影響。你能否評論一下你們正在做哪些類型的調整、目前locums的派遣強項在哪些領域,並且如果我理解正確的話,這是一個利潤率壓力——能否再多闡述一點?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
So there's two things about it in the locum space. One is you're seeing the same build pay pressure that you're seeing everywhere else as the primary factor. And so the pay expectations in Locums is even more acute thing you would even see in parts of Nurse and Allied just because of the shortage of physicians and the demand for them because they're so closely tied to revenue. So it really has been more of a bill pay spread Underneath that, we still see some strong demand in CRNA, which does tend to have lower margins than some of the other specialties. But besides that, I think the big headline is the same pressure that we're seeing in other parts of our business.
所以在locum領域有兩件事。第一,你看到的主要因素是與其他地方一樣的帳單/薪資壓力(bill-pay pressure)。因此,Locums的薪資期望甚至更為尖銳,可能比護理與醫技(Nurse and Allied)的某些部分還更明顯,因為醫師短缺、需求旺盛,而且他們與收入的連動非常緊密。所以這確實更多是帳單與薪資價差(bill-pay spread)問題。在此之下,我們仍看到CRNA(麻醉護理師)需求強勁,而這通常比其他一些專科的利潤率更低。但除此之外,我認為最大的重點就是我們在業務其他部分也看到的同樣壓力。
AJ Rice - Analyst
AJ Rice - Analyst
Okay. Last question for me would relate to the comments you made, and obviously, doing math on the fly always gets me in trouble. But you're saying, I think if you take out the strike revenue for the fourth quarter and have run rate and you apply like an 8% EBITDA margin to that would sort of suggest on an annualized basis, you're jumping off at a $200 million EBITDA run rate.
好的。我最後一個問題會跟你剛才的評論有關,而且顯然即席算數總是會讓我惹麻煩。但你們的意思是,我想如果把第四季的罷工收入拿掉,然後用運行率並套用大約8%的EBITDA利潤率,按年化來看,似乎表示你們的EBITDA運行率起跳點是2億美元。
And now I know Randy just said that if you could get the international back, that would be 100 basis points, which would make a difference. But is that the jumping off point? And then are there obvious places to look for improved performance off of that exit year run rate from '24 to '25?
而且我知道Randy剛說,如果國際業務回來,會有100個基點的提升,這會帶來差異。但那就是起跳點嗎?然後,從2024年退出年度的運行率到2025年,有沒有明顯可以期待改善表現的地方?
Randle Reece - Investor Relations
Randle Reece - Investor Relations
When you go to modeling 2025, I suggest that you do normalize Q4, but it's a little bit different than the way you present it. The midpoint of revenue guidance, excluding the revenue that we don't expect to recur would be $650 million. The midpoint of the adjusted EBITDA margin guidance would be about 8.3%. So you're several million higher on the quarterly run rate EBITDA there.
當你開始建模2025年時,我建議你要把第四季做正常化(normalize),但方式跟你呈現的有點不同。收入指引的中位數(midpoint),扣除我們預期不會重複發生的收入後,會是6.5億美元。調整後EBITDA利潤率指引的中位數大約是8.3%。所以你在季度EBITDA運行率上會高出幾百萬美元。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
And then A.J., the other things that we took out because it's hard to predict is strike. And so we have the largest labor disruption pipeline since I've been here. there's a number of CVAs that are up next year. It's hard to predict, but it is a very strong pipeline. We just don't put that in there. And then you would start to see modest growth coming off the fourth quarter, particularly in businesses like PLS and language services that are seasonally low in the fourth quarter.
然後A.J.,我們另外拿掉、因為很難預測的,是罷工。所以我們有我在這裡以來最大的勞資衝突(labor disruption)管線;明年有不少CVA到期。這很難預測,但管線非常強。我們只是沒有把它放進去。然後你會開始看到從第四季往上有溫和成長,特別是在像PLS和語言服務這些在第四季季節性偏低的業務。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
Yes. We normalized Q1 in a conservative way, just taking out all of the labor disruption revenue. But we expect to have material labor disruption revenue next year.
是的。我們以保守的方式把第一季做了正常化(normalized),就是把所有勞資衝突收入都拿掉。但我們預期明年會有可觀的勞資衝突收入。
Operator
Operator
Tobey Summer, Truist.
Tobey Summer,Truist。
Tobey Summer - Analyst
Tobey Summer - Analyst
I wanted to ask something about orders. What's the change in the volume of orders that are coming in around the prevailing bill rates of travelers you have on assignment today? I just want to make sure that we're trafficking and sort of data and we're not -- that's more indicative of demand that could reasonably be filled instead of also including outlier rates that are too low to be profitably filled? Maybe you've already kind of scrubbed the data and you're conveying it that way, I just don't know.
我想問一個關於訂單(orders)的问题。以你們今天在派遣中的旅遊護理人員(travelers)的主流帳單費率(prevailing bill rates)來看,進來的訂單量有什麼變化?我只是想確認,我們是在追蹤並使用這類數據,而不是——那更能反映合理可被填補的需求,而不是也包含那些費率低到無法有利可圖地填補的離群值(outlier rates)?也許你們已經某種程度清理過數據並以那種方式傳達了,我只是不了解。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
If we look at -- I guess, until you sometimes go out and see if you can get a clinician to be interested in that role, there's a piece of them that I think there's a group of them, Tobey, that are just unfillable as they come in. There's a group of them that's probably in some middle ground. And then there's a group that is fillable. I don't have a specific number of the incremental number of orders coming in that we would put in those categories because part of the dynamic that's affecting it is if you look at underlying key expectations, they're very dynamic. And so annualized RM Pay is in the high single digits.
如果我們看——我想,除非你有時候真的出去看看能不能讓某位臨床人員對那個職位感興趣,否則其中有一部分——我認為有一群訂單,Tobey,進來時就是無法填補的。有一群可能介於中間地帶。然後有一群是可以填補的。我沒有一個具體數字來說明新增進來的訂單中,我們會把多少歸到這些類別,因為影響它的動態之一是,如果你看底層的關鍵薪資期望,它們變動非常快。因此,年化的RM Pay是在高個位數(high single digits)。
And so what they would have expected in the first quarter of this year that's also dynamic. But what we've seen overall and how we look at, I'd say, the orders that we think are -- we see nobody feel that number has increased quarter over quarter.
因此,他們在今年第一季原本預期的情況也是動態變化的。但就我們整體所看到的,以及我們的觀察方式來說,我會說,我們認為的訂單——我們沒有看到有人覺得那個數字較上一季有所增加。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
We did note, Tobey, that our vendor-neutral and VMS business, we saw 14% of orders unfilled in Q3 that's probably representative of the proportion of orders that are kind of an extreme on the pricing.
Tobey,我們確實注意到,在我們的供應商中立(vendor-neutral)與 VMS 業務中,我們看到第三季有 14% 的訂單未被填補,這大概代表了那類在定價上屬於相對極端的訂單占比。
Tobey Summer - Analyst
Tobey Summer - Analyst
So when you convey the percentage change in orders compared in the prior periods of pre-pandemic, are you adjusting and filtering out orders that are sort of at a nonsensical price to the market conditions?
所以,當你在傳達相較於疫情前各期間的訂單百分比變動時,你是否有調整並篩除那些在市場條件下價格不太合理的訂單?
Randle Reece - Investor Relations
Randle Reece - Investor Relations
No.
沒有。
Tobey Summer - Analyst
Tobey Summer - Analyst
Okay. Maybe what's a fair conversion kind of assumption from EBITDA to free cash? And how do you see CapEx because we just had some pretty heavy lifting for CapEx and with declining margins? I'm just trying to refine what the free cash profile looks like at the company.
好的。那麼,從 EBITDA 轉換到自由現金流,一個合理的轉換假設大概是多少?另外你怎麼看資本支出(CapEx),因為我們剛做了一些相當吃重的 CapEx 投入,而且利潤率在下滑?我只是想更精準地了解公司自由現金流的輪廓會是什麼樣子。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
We would normally just assume 65% conversion of adjusted EBITDA to operating cash flow, and then you would have CapEx. We expect our CapEx number to be lower in the fourth quarter just reducing it in line with revenue that we have -- we completed a lot of projects this year. That's the higher CapEx that we've had.
我們通常會假設調整後 EBITDA 轉換為營運現金流的比例為 65%,然後再扣除 CapEx。我們預期第四季的 CapEx 會較低,會隨著我們的營收水準下調——我們今年已完成了許多專案。這就是我們今年 CapEx 較高的原因。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
And Tobey, just to give details on some of the projects we completed. So we talked a lot about ShiftWise Flex and the work that we've done there. We are -- we should be virtually complete the replatforming of our BNS clients by the end of this year. And we will be the majority completed with our MSP clients on ShiftWise Flex, and we'll finish that up in Q1. The same thing for our applicant tracking system and getting that completed this year.
Tobey,補充一些我們已完成專案的細節。我們談了很多 ShiftWise Flex 以及我們在那方面所做的工作。我們——到今年年底,我們應該幾乎完成將 BNS 客戶重新平台化(replatforming)。而我們的 MSP 客戶在 ShiftWise Flex 上也將完成大部分,我們會在第一季把剩下的完成。同樣地,我們的應徵者追蹤系統(ATS)也會在今年完成。
So there's some significant projects that we have in place that will be done. So between that completion and where we are from a kind of overall revenue standpoint, we will be down in CapEx next year.
所以我們有一些重要的專案即將完成。因此,隨著這些專案完成,以及從整體營收水準的角度來看,我們明年的 CapEx 會下降。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
You may have noticed that our operating cash flow as a percentage of adjusted EBITDA seemed quite good this year to date. And we did have a three-day improvement in DSO in the third quarter. Our operating cash flow this quarter included an outflow for legal settlement, so it would have been a really boom quarter without that.
你可能注意到,今年截至目前,我們的營運現金流占調整後 EBITDA 的比例看起來相當不錯。而且第三季我們的 DSO(應收帳款週轉天數)改善了 3 天。本季的營運現金流包含一筆法律和解的現金流出,若沒有那筆,本來會是一個非常亮眼的季度。
Tobey Summer - Analyst
Tobey Summer - Analyst
If I may sneak one more in. Under the last -- I guess, the last 1.5 years or so, you've kind of reengaged from a sales perspective with the market and customers that you kind of were calling on, unified a bunch of brands. What sort of traction are you seeing related to that? And is it sort of fully in the business as of the third quarter? Or do you still think that you're in the ramping stage of that reengagement process with noncore customers from three or four years ago.
如果我可以再塞一個問題。在過去大概 1.5 年左右,你們從銷售角度重新與市場及客戶互動,重新拜訪你們曾經接觸的客戶,並整合了多個品牌。你們在這方面看到什麼樣的進展?到第三季為止,這些是否已完全反映在業務中?還是你仍認為,對於三、四年前的非核心客戶,這個重新互動的過程仍處於爬坡階段?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
I think we are still in the ramping phase and not the least of which is because of the typical sales cycle. Depending on what it is on language services, that sales cycle is not as long. If you're talking about an MSP, it can be a year to a year plus. And so the signs that we have around the reengagement of all the work that we've been doing, not just with clients and prospects, but just aligning ourselves more broadly across the market. It's from a sales pipeline standpoint, we've seen quarter-over-quarter growth.
我認為我們仍在爬坡階段,其中一個重要原因是典型的銷售週期。視語言服務的內容而定,銷售週期不會那麼長。如果談的是 MSP,可能需要一年到一年以上。因此,我們看到的重新互動跡象——不只是與客戶和潛在客戶的互動,也包括我們在更廣泛市場上的對齊——從銷售管線的角度來看,我們看到逐季成長。
The biggest growth factor in that has been growth in vendor-neutral prospects. So when we launched ShiftWise Flex really at the beginning of the year, we have been very successful in building a pipeline around those capabilities. We've also seen progression through the pipeline of those opportunities. So those are the -- that's one of the leading indicators we would look at. We're in a net win position year to date for MSPs which is an improvement from what we saw last year.
其中最大的成長因素,是供應商中立(vendor-neutral)潛在客戶的成長。所以當我們在年初真正推出 ShiftWise Flex 時,我們在圍繞這些能力建立管線方面非常成功。我們也看到這些機會在管線中持續推進。所以這些是——這是我們會觀察的領先指標之一。截至目前,我們在 MSP 上處於淨贏(net win)狀態,這比去年看到的情況有所改善。
And then the final piece, and I know we mentioned this is in our comments is if we look at our top clients, we improved the average number of solutions that we have with them. So it's -- we want to get our solutions in pipelines and then we want to be able to expand with that client into more solution set.
最後一點,我知道我們在評論中也提到:如果看我們的前幾大客戶,我們提升了與他們合作的平均解決方案數量。所以——我們希望先把解決方案放進管線,接著能夠在同一客戶那裡擴展到更多的解決方案組合。
Operator
Operator
Joanna Gajuk, Bank of America.
Joanna Gajuk,美國銀行。
Joanna Gajuk - Analyst
Joanna Gajuk - Analyst
So maybe first, a follow-up, maybe I missed it. But when it comes to the demand trends, I know you compared it to 2019, but did you talk about I guess, year to date or sequentially where you're seeing the demand? And I guess, as it relates also to seasonal orders, any commentary there?
那我先追問一下,可能我漏聽了。但就需求趨勢而言,我知道你們拿 2019 年做比較,但你們是否談到截至目前(year to date)或按季(sequentially)你們看到的需求狀況?另外,與季節性訂單相關的部分,有沒有任何評論?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. So if we look at demand in different businesses, so while Travel Nurse demand has increased since the beginning of the second quarter, and we've seen that continue into the fourth quarter. Part of the third quarter demand was seasonal orders, Joanna. And while that demand has been welcome since April, you are still tracking about 35% below what you would have seen in pre-COVID. We're seeing healthy demand in Allied and at levels above what you saw in 2019. We're seeing lower demand in locums than last year, still healthy and above 2019.
有。如果我們看不同業務的需求,旅行護理(Travel Nurse)需求自第二季初以來有所增加,而且我們看到這個趨勢延續到第四季。第三季的部分需求是季節性訂單,Joanna。雖然自四月以來這樣的需求是令人樂見的,但你仍大約比疫情前的水準低 35%。我們看到 Allied 的需求健康,且水準高於 2019 年。我們看到 locums 的需求低於去年,但仍然健康且高於 2019 年。
Joanna Gajuk - Analyst
Joanna Gajuk - Analyst
Okay. That's helpful. And I guess another follow-up on the discussion on the gross margins. So you're saying that the rates are stable, but there's still this pressure on compensation. So how do you expect this to play out into next year?
好的。這很有幫助。另外再追問一下關於毛利率的討論。所以你們是說費率穩定,但薪酬仍有壓力。那你們預期這在明年會如何發展?
I understand there could be some mix benefit if this international business comes back and such. But kind of just on maybe just the nurse piece, how you expect the gross margin? Because also you talked about competition there. So is there any indication of any change in competition as it like easing that pressure?
我理解如果國際業務回來之類的,可能會有一些組合(mix)上的助益。但就——也許就護理這一塊,你們預期毛利率會怎麼走?因為你們也談到那裡的競爭。所以在競爭方面,有沒有任何跡象顯示競爭正在改變、從而緩解那種壓力?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
When you go back and look at cycles and the part of the cycle that we're in, you will sometimes see an overcorrection that will work its way out, and you'll see some margin improvement as you come out of that. And so we would expect that to happen. That will take a bit of time for that to work through. So we started to see part of it is an overcapacity of suppliers coming out of COVID. We've started to see that.
當你回頭看各個循環以及我們目前所處的循環階段時,有時你會看到一種過度修正,之後會逐步消化,並在走出那段期間時看到一些利潤率改善。因此我們預期會發生這種情況。但這需要一些時間才能完全反映出來。所以其中一部分是疫情後供應商產能過剩。我們已經開始看到這一點。
We saw a supplier retrench from the Travel Nurse business in the third quarter. So I think you're starting to see a bit of that rationalization. So that would be, I'd say, the demand piece of it. If you look at from a mix standpoint, we would expect our biggest mix challenge in Nurse has been the international nurse in visa retrogression. We would expect that to taper off in the second quarter of 2025.
我們看到有一家供應商在第三季從旅遊護理師(Travel Nurse)業務中縮減撤出。所以我認為你開始看到一些這類的理性化調整。因此我會說,那會是需求面的部分。如果從組合(mix)的角度來看,我們預期護理師業務最大的組合挑戰一直是國際護理師受到簽證倒退(visa retrogression)的影響。我們預期這個影響會在2025年第二季趨緩。
And then we would expect to see as we exit 2025 at the end, some growth that we'd really see accelerate in 2026. And that will have a -- as that business both tapers off. And then as we get back into a growth mode for that business, that will have a positive impact on gross margin and EBITDA margin both for Nurse and Allied and for our consolidated results.
接著我們預期在2025年年底、也就是我們退出2025年時,會看到一些成長,而這個成長在2026年會真正加速。而這將會有一個——隨著該業務逐步趨緩。然後當我們讓該業務回到成長模式時,這將對護理師與醫技(Allied)的毛利率與EBITDA利潤率,以及我們合併結果,都帶來正面影響。
Joanna Gajuk - Analyst
Joanna Gajuk - Analyst
Right. I understand. And if I may squeeze a last one on the -- when you were talking about competition and some people leaving the market or not offering that particular service up, do you expect maybe some assets to be picked up as in like consolidation? Is there something that you would be interested in?
好的。我了解。如果我可以再擠最後一個問題——當你談到競爭,以及有些人離開市場或不再提供那項特定服務時,你是否預期可能會有一些資產被收購、也就是像產業整併那樣?這是你們會有興趣的事情嗎?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
I think if you just look at the shape of the industry and some of the fragmentation, along with clients wanting more tech-enabled solutions. I think those two things will drive consolidation in the industry. For us, we always look at opportunities that are going to either give us some unique capabilities that we don't have or would give us an ability to scale something where we see significant opportunity.
我認為如果你看看產業的樣貌以及某種程度的分散性,再加上客戶希望有更多科技賦能(tech-enabled)的解決方案。我認為這兩件事會推動產業整併。對我們而言,我們一直在看那些要嘛能帶給我們一些我們目前沒有的獨特能力、要嘛能讓我們把某個我們看到有重大機會的項目做規模化的機會。
Operator
Operator
Brian Tanquilut, Jefferies.
Brian Tanquilut,Jefferies。
Brian Tanquilut - Analyst
Brian Tanquilut - Analyst
Maybe just a question on -- Cary, on seasonal placements, just to follow up on Joanne's question. I don't think we've touched on kind of like commentary, qualitative commentary in terms of expectations for Q1. How should we be thinking about that progression from Q4 to Q1, given what you're seeing with seasonal orders heading into this quarter end to next?
也許問一個問題——Cary,關於季節性派遣(seasonal placements),只是跟進Joanne的問題。我想我們還沒有談到對Q1的預期之類的評論、定性評論。考量你們看到本季季末到下季之間的季節性訂單狀況,我們應該如何看待從Q4到Q1的變化走勢?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
We don't have as much transparency at this point into Q1. But what you would typically see if we look at winter orders, as an example, we saw this last year, and we saw this play through again this year. We had start date last year that went into Q1, and we have that same phenomenon now. So that will be a help for us. So we would expect that to be helpful from a Q1 standpoint, overall.
目前我們對Q1沒有那麼高的透明度。但通常如果以冬季訂單為例,我們去年看到過,今年也再次看到同樣的情況。去年有一些開始日期落在Q1,今年現在也有同樣的現象。所以這會對我們有幫助。因此整體而言,從Q1的角度我們預期這會帶來正面幫助。
We typically after Q1 would see some drop off of winter orders, but that really happens more Q2 versus Q1.
通常在Q1之後,我們會看到冬季訂單有些下滑,但那其實更多發生在Q2而不是Q1。
Brian Tanquilut - Analyst
Brian Tanquilut - Analyst
Maybe I'll follow up on that, right, tying back to AJ's question from earlier. I mean if we look at your implied guidance for Q4 and then adjust for that seasonal factor of Q4 and Q1, we're landing at roughly a $200 million run rate. So just curious what would be the missing pieces to get to a number that grows that significantly from that sort of run rate?
也許我再跟進一下,對吧,連回AJ先前的問題。我的意思是,如果我們看你們對Q4的隱含指引,然後再針對Q4與Q1的季節性因素做調整,我們大概落在約2億美元的年化運行率(run rate)。所以我只是好奇,要讓數字從那樣的運行率顯著成長,缺少的拼圖會是什麼?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
While we don't give guidance, what we try to do is give you a core taking everything out, including labor disruption, which we typically have some in. It's just hard to predict. I think AJ went to a low-end range of guidance on EBITDA margin would be kind of thing one that you would look through. And then if you go back and look at what you would expect in different businesses, you would typically, in PLS and language services, particularly with some of the commentary that I gave about language services and the client deployment, you would see growth off of seasonal Q4 lows. And we don't typically -- in Nurse and Allied, you would see more of the Traveler decline in second quarter, not in the first quarter.
雖然我們不提供指引,但我們嘗試做的是給你一個核心狀況,把所有因素都剔除掉,包括我們通常會遇到的一些勞動中斷(labor disruption)。那只是很難預測。我認為AJ提到EBITDA利潤率指引區間的低端,會是你要看穿(look through)的第一件事。然後如果你回頭看不同業務的預期表現,通常在PLS與語言服務方面,特別是結合我對語言服務與客戶部署所做的一些評論,你會看到在Q4季節性低點之後的成長。而我們通常——在護理師與醫技(Nurse and Allied)方面,你會在第二季而不是第一季看到更多旅遊人力(Traveler)的下滑。
Operator
Operator
Constantine Davides, Citizens JMP Securities.
Constantine Davides,Citizens JMP Securities。
Constantine Davides - Analyst
Constantine Davides - Analyst
One follow-up on the international business. Did you provide a run rate on how that business performed in the third quarter? And Cary, just updated thoughts on when you say it tapers out second quarter '25, you could just give a little bit more color there on where you think that bottoms?
關於國際業務的一個追問。你們是否提供過該業務在第三季表現的運行率(run rate)?另外Cary,當你說它會在2025年第二季趨緩結束時,能否再多補充一些細節,談談你認為它會在什麼水準觸底?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. So if you look at the international business, and we take what it looks like pre-Visa retrogression, that was a $225 million business. We expect in Q4 for it to be $180 million. And then we would expect another year-over-year impact of $60 million in 2025. That's a year-over-year comparison.
有的。所以如果你看國際業務,並以簽證倒退(Visa retrogression)之前的狀況來看,那是一個2.25億美元的業務。我們預期Q4會是1.8億美元。然後我們預期2025年還會有6,000萬美元的年對年影響。那是年對年比較。
If we look at the cadence of that in 2025, you would expect it to have a meaningful tapering in Q2. And then we would get to growth as we end 2025.
如果看2025年的節奏,你會預期它在Q2會有明顯的趨緩。然後在2025年接近年底時,我們會回到成長。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
We're looking at the gross margin headwind from international tapering from being about 70 basis points to about 40 basis points in Q1 and then minuscule after that.
我們預估國際業務趨緩對毛利率的逆風,將從約70個基點降至Q1約40個基點,之後就微乎其微。
Constantine Davides - Analyst
Constantine Davides - Analyst
And then Cary, just following up on this notion that you alluded to, just top line having an average of 10 solutions. Can you just talk about how you maybe broadly define discrete solution, how that penetration has changed in the past year or two? And I guess, where are the best opportunities to further penetrate those clients entering 2025?
另外Cary,再跟進你提到的這個概念,也就是營收端平均有10個解決方案。你能否談談你們大致如何定義「單一(離散)解決方案」,以及這個滲透率在過去一兩年如何變化?以及我想問的是,進入2025年後,進一步加深這些客戶滲透的最佳機會在哪裡?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
So we look at solutions where we'll go and say our major solution categories under our three business lines, so you would have Travel Nurse in there, you'd have international, you'd have labor disruption we would have per diem. You go down the list then for POS and for technology and workforce solutions. That number has gone from, call it, about 9 to now 10 solutions. The things that we have seen over the past couple of quarters, there's been a renewed interest in revenue cycle management. I think as systems have focused on really maintaining and growing their revenue base.
我們看待解決方案的方式是:我們會去界定三條業務線下的主要解決方案類別,例如其中會包含旅遊護理師(Travel Nurse)、國際業務、勞動中斷(labor disruption)、以及按日派遣(per diem)。接著你再往下列出POS,以及科技與人力解決方案。那個數字大約從9個增加到現在的10個解決方案。過去幾個季度我們看到的事情是,對營收循環管理(revenue cycle management)的興趣重新升溫。我認為這是因為醫療系統專注在維持並成長其營收基礎。
We've seen an interest in local programs getting managed more centrally out of teams that may have helped manage Nurse and Allied program. We actually have -- are building a strong locums pipeline in vendor neutral. We're seeing the same trend there. And we just launched locums capabilities in ShiftWise Flex this past quarter. So we think we're well positioned to be able to serve a number of our MSP clients who don't have locums with us in a different way than we were even two quarters ago. We've seen interest in workforce advisory and planning and scheduling.
我們也看到對於在地方案(local programs)由更中央化的方式來管理的興趣提升,這些管理往往來自原本可能協助管理護理師與醫技(Nurse and Allied)方案的團隊。我們其實已經——正在供應商中立(vendor neutral)模式下建立強勁的代班醫師(locums)管線。我們在那裡也看到同樣的趨勢。而且我們在本季度剛於ShiftWise Flex推出代班醫師(locums)能力。因此我們認為,我們已具備良好定位,能以不同於甚至兩個季度前的方式,服務許多目前尚未透過我們導入locums的MSP客戶。我們也看到對人力顧問(workforce advisory)、規劃與排班的興趣。
Constantine Davides - Analyst
Constantine Davides - Analyst
And are those businesses -- those clients that sort of have that -- those 9 or 10 solutions, are you seeing that they're just inherently more sticky than the rest of your book?
那麼這些企業——也就是那些擁有大約 9 或 10 項解決方案的客戶——您是否看到他們相較於您其他客戶組合,天生就更具黏著度?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
They're inherently more sticky, and it gives us more ways to engage with different parts of the organization. So between HR, finance, procurement, technology. Those solutions at different points in time will pull different leadership. And so it gives us an opportunity to not just be more sticky, but to have broader relationships across the system.
他們天生就更具黏著度,而且這也讓我們有更多方式與組織內不同部門互動。因此在 HR、人資、財務、採購、科技之間。這些解決方案在不同時間點會帶動不同層級的領導參與。因此這讓我們不僅能更具黏著度,也能在整個體系中建立更廣泛的關係。
Operator
Operator
Jeff Silber, BMO Capital Markets.
Jeff Silber,BMO 資本市場。
Jeff Silber - Analyst
Jeff Silber - Analyst
I know it's late. I'll just ask one. And maybe a stupid question, so forgive me. You've talked a few times about, I guess, the imbalance between what the providers are willing to pay, what the clinicians are willing to accept. Is there anything you or anybody else in the industry can proactively do to narrow that gap? Or is it just something we have to wait for the market to kind of work itself out?
我知道時間有點晚了。我就問一個。也許是個蠢問題,先請見諒。您多次談到,我想是供應方願意支付的金額與臨床人員願意接受的金額之間的不平衡。您或產業內其他人是否能主動做些什麼來縮小這個差距?還是這只是我們必須等待市場自行調整的事情?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
The thing that is being done, there's a lot of market data and transparency, including data that we have and that we've included in ownership ShiftWise Flex platform. Jeff, if you think about how fast some of this normalized, you've had two things that have both been fairly dynamic. One is when you look at our starting point of where bill rates were at the end of COVID, they neutralized -- they went down pretty quickly. At the same time, clinician expectations don't change as fast. And between their expectations not changing fast and underlying wage increases that are happening across health care workforce.
目前正在做的事情是:有大量的市場數據與透明度,包括我們擁有的數據,且我們已將其納入我們所擁有的 ShiftWise Flex 平台。Jeff,如果你想想其中一些事情正常化的速度,你會看到有兩件事都相當動態。第一是,當你看我們的起點——也就是 COVID 結束時的帳單費率(bill rates)——它們已經中性化——下降得相當快。同時,臨床人員的期望不會變得那麼快。而在他們的期望無法快速改變,以及醫療照護人力整體薪資上升的背景之下。
That's the dynamic piece that it really does need to work its way out. And we're seeing that happen where we see clients increasing bill rates. It's in either incredibly needed physician specialties that are hard to fill. And so you're starting to see some of that behavior that you would expect from a kind of normalized market happening but there's still a lot more that has to happen.
這就是那個動態部分,確實需要讓它自行逐步調整到位。而我們也看到這正在發生,因為我們看到客戶正在提高帳單費率。這通常出現在極度需要、且難以補足的醫師專科。因此你開始看到一些符合市場正常化預期的行為正在發生,但仍然還有很多事情需要發生。
Operator
Operator
Bill Sutherland, The Benchmark Company.
Bill Sutherland,Benchmark Company。
Bill Sutherland - Analyst
Bill Sutherland - Analyst
Best wishes, Jeff. I'll keep it brief, too. Maybe ask two. Following up on Jeff's question about the hospital kind of mindset here as we head into the winter flu season. And patient census assuming a kind of a normal season, do you -- is there a sense that they've got more flexibility that they can work with in-house and they're pretty happy with their retention and hiring?
祝福你,Jeff。我也簡短一點。也許問兩個。延續 Jeff 的問題,談到我們進入冬季流感季時醫院端的心態。在假設病患住院人數(patient census)是一個正常季節的情況下,您是否覺得他們有更大的彈性可以用內部人力來應對,而且對留任與招募相當滿意?
Or is there a sense that this is maybe the thing that switches particularly given where the premiums are right now for travelers and others.
或者是否覺得,考量到目前對旅派人員(travelers)及其他人員的溢價水準,這可能會成為一個轉折點?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
I think it depends on the client. We are -- there's been a significant amount of permanent hiring really across the board. And that needed to happen, you need -- they needed to rebuild their permanent base. So for some clients, they may be looking and saying, "Hey, I still have a little bit of capacity." We're seeing some clients where they really need the contingent workforce to come in, and that's where we're seeing bill rate increase to be able to attract that talent. You typically, in December, especially over the holidays, that's not as attractive sometimes for us to take those assignments.
我認為這取決於客戶。我們——整體而言,各方面都出現了相當大量的永久性招募(permanent hiring)。而那是必要的,他們需要——他們需要重建其永久人力基礎。因此對某些客戶而言,他們可能會看著並說:「嘿,我還有一點容量。」我們也看到一些客戶確實需要臨時/彈性人力(contingent workforce)進來,而我們看到帳單費率上升,才能吸引到這些人才。通常在 12 月,尤其是假期期間,對我們來說接這些任務有時候沒那麼有吸引力。
But we would expect that just with the underlying pressure of increased patient demand, and this normal contingent premium spread that we're at right now, we're actually at the lower end of historical averages. It now really is becoming the affordable option to get some excess clinician capacity for these systems.
但我們預期,隨著病患需求增加的基本壓力,以及我們目前所處的這個正常的臨時人力溢價差(contingent premium spread),其實我們正處於歷史平均的較低端。因此現在,對這些體系而言,取得一些額外的臨床人力容量,確實正在成為一個可負擔的選項。
Bill Sutherland - Analyst
Bill Sutherland - Analyst
Got you. And last one, SG&A, the assumptions or kind of where you're seeing it this quarter, did that require any more headcount actions? Or do you plan any further actions as you head into the new year?
了解。最後一個,關於 SG&A,本季你們的假設或你們看到的情況,是否需要採取任何額外的人力編制(headcount)措施?或者在進入新的一年時,你們是否計畫採取進一步行動?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
It didn't include any headcount actions. We had taken some reduction in the beginning of -- actually, we did do in the beginning of the third quarter, at the very beginning the third quarter. So we did that, that you'll see play through. And we really are looking at it as demands in different businesses. we see them.
這裡面沒有包含任何人力編制措施。我們在——其實是在第三季一開始就做了一些縮編,在第三季非常一開始的時候。所以我們做了那個,你會看到其效果逐步反映出來。而我們確實是把它視為不同業務中的需求——我們看得到它們。
We want to make sure that we are positioned to take advantage of them. And at the same time, we always look at ways for us to be prudent in managing our expenses.
我們希望確保我們已就位,能夠把握這些機會。同時,我們也一直在尋找方法,以審慎的方式管理我們的費用。
Operator
Operator
I'm showing no further questions at this time. I'd now like to turn it back to Cary Grace for closing remarks.
我目前顯示沒有進一步的提問。現在我想把時間交回給 Cary Grace 作結語。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Thank you for your interest in AMN Healthcare, and thank you to all of AMN's dedicated team members and clinicians to make a positive impact on the health of so many. We appreciate everything you do.
感謝您對 AMN Healthcare 的關注,也感謝 AMN 所有敬業的團隊成員與臨床人員,為如此多人的健康帶來正向影響。我們感謝你們所做的一切。
Operator
Operator
Thank you for your participation in today's conference. This concludes the program. You may now disconnect.
感謝您參與今天的電話會議。本節目到此結束。您現在可以斷線。